Mechanistically, tumor-infiltrating IL-1β activated IL-17A+ γδ T cells, enhancing the priming and recruitment of IFN-γ-producing CD8+ T cells that exert antitumor effects [48]. The gene discussed is CD8A; the disease is neoplasm.